SNORD67: A Potential Drug Target and Biomarker (G692108)

Target Name: SNORD67

NCBI ID: G692108

SNORD67

Other Name(s): small nucleolar RNA, C/D box 67 | HBII-166 | Small nucleolar RNA, C/D box 67

SNORD67: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the most well-known snRNAs is SNORD67, which is located in the C/D box region of the nucleus and is involved in the regulation of various cellular processes.

SNORD67 is a key regulator of gene expression, and it has been shown to play a role in the regulation of cell growth, differentiation, and apoptosis. SNORD67 has been shown to interact with a variety of protein partners, including the transcription factors p53 and NF -kappa-B.

In addition to its role in gene expression regulation, SNORD67 has also been shown to serve as a potential drug target. SNORD67 has been shown to be a good candidate for small molecule inhibitors, with several studies suggesting that inhibition of SNORD67 activity may be a promising new approach for the treatment of various diseases.

One of the key challenges in studying SNORD67 is its complex nuclear localization. While it is well known that SNORD67 is located in the nucleus, its subcellular localization to specific gene expression sites is not as well understood. recent studies have used techniques such as RNA sequencing and biochemical assays to show that SNORD67 is highly enriched in specific cellular compartments, including the nucleoplasm and the nuclear envelope.

SNORD67 has also been shown to play a role in the regulation of cellular apoptosis. Apoptosis is a critical mechanism of cell death that is regulated by a variety of factors, including the production of reactive oxygen species (ROS). SNORD67 has been shown to be involved in the regulation of apoptosis by ROS, with studies showing that inhibition of ROS production by SNORD67 can protect cells from oxidative stress-induced apoptosis.

In addition to its role in apoptosis regulation, SNORD67 has also been shown to play a role in the regulation of cell growth and differentiation. Cell growth and differentiation are critical processes that are regulated by a variety of factors, including the production of progeny, the maintenance of stem cells, and the regulation of cell-cell interactions. SNORD67 has been shown to be involved in these processes, with studies showing that inhibition of SNORD67 activity can lead to increased cell proliferation and the loss of stem cell properties.

Despite its potential as a drug target, SNORD67 is still a poorly understood molecule. The functions of SNORD67 are still mainly described in in vitro studies and animal models. Therefore, further studies are needed to fully understand the role of SNORD67 in cellular processes and to explore its potential as a drug target.

In conclusion, SNORD67 is a well-known small nucleolar RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. Its subcellular localization and its involvement in the regulation of cell growth, apoptosis and differentiation make it a promising candidate for small molecule inhibitors. Further studies are needed to fully understand its functions and to explore its potential as a drug target.

Protein Name: Small Nucleolar RNA, C/D Box 67

The "SNORD67 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD67 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets